₹ 5.4 Cr
Volume transacted
42.4 K
stocks traded
Last Updated time: 05 Nov 15:30 PM
Dr Reddys Laboratories Ltd
NSE: DRREDDY
YEARHIGH
₹ 1420.2
Last updated on: Nov 04, 2024
Open Demat Account
Enter your mobile no. to continue
+91
*By signing up you agree to our terms & conditions
50 Years
of Trust & Legacy
₹0 AMC
for First Year
₹0 Brokerage
on Delivery, Intraday, Currency and NSE F&O
No data available
* All values are consolidated
Last Updated time:
The current market price or CMP refers to the price at which the securities are trading in the share market. Current price in Over-the-counter costs: The following current price depends upon the bid price & the asking price when a financial asset is sold over-the-counter(OTC). Current Price in Bond Market: The current price of a bond is determined by measuring the actual interest rate against the bid-related interest rate. The par or the face value is then calculated to represent the remaining interest payments due which occur before the maturity of the bond.
1M
1Y
3Y
5Y
Date | Price | Day Open | Day High | Day Low |
---|
04 Nov 2024 | 1267.95 | 1262.85 | 1276.75 | 1250.1 |
01 Nov 2024 | 1258.55 | 1281.95 | 1285 | 1213.2 |
31 Oct 2024 | 1274.25 | 1262.15 | 1283.25 | 1247.4 |
30 Oct 2024 | 1250.2 | 1275 | 1275 | 1229.1 |
29 Oct 2024 | 1275.1 | 1325.05 | 1333.65 | 1264.25 |
28 Oct 2024 | 1312.4 | 1328.9 | 1328.9 | 1291.6 |
25 Oct 2024 | 1302.83 | 1316 | 1316 | 1290.22 |
24 Oct 2024 | 1316.53 | 1327.76 | 1327.78 | 1315.18 |
23 Oct 2024 | 1321.27 | 1332.05 | 1336.75 | 1318.4 |
22 Oct 2024 | 1332.05 | 1350.99 | 1351 | 1328 |
Date | Price |
---|---|
04 Nov 2024 | 1267.95 |
01 Nov 2024 | 1258.55 |
31 Oct 2024 | 1274.25 |
30 Oct 2024 | 1250.2 |
29 Oct 2024 | 1275.1 |
28 Oct 2024 | 1312.4 |
25 Oct 2024 | 1302.83 |
24 Oct 2024 | 1316.53 |
23 Oct 2024 | 1321.27 |
22 Oct 2024 | 1332.05 |
Market Value
₹ 0
Asset Value
₹ 0
* All values are in Rupees
Historical Revenue of Dr Reddys Laboratories Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.
No data available
* All values are in ₹ crore
Historical Net Profit of Dr Reddys Laboratories Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
No data available
* All values are in ₹ crore
Aurigene Oncology receives nod for Phase 2 clinical trial for Ribrecabtagene autoleucel
Aurigene Oncology, a wholly-owned subsidiary of Dr. Reddy's Laboratories has announced the...
08 Oct 202418:16
Dr Reddys announces incorporation of new step-down subsidiary in Denmark
Dr. Reddy's Laboratories SA, Switzerland, (DRSA) a wholly owned subsidiary of Dr Reddys ...
05 Oct 202411:37
Dr Reddys acquires Haleon plc brands in NRT category
Dr Reddys Laboratories announced that its wholly owned subsidiary, Dr. Reddy's Laboratorie...
30 Sep 202417:31
Dr Reddys Laboratories schedules board meeting
Dr Reddys Laboratories will hold a meeting of the Board of Directors of the Company on 5 N...
23 Sep 202410:11
Dr Reddys Laboratories Ltd down for fifth straight session
Dr Reddys Laboratories Ltd is down for a fifth straight session today. The stock is quotin...
19 Sep 202413:35
Dr. Reddy's API manufacturing unit (CTO-6) completes USFDA inspection
Dr. Reddy's Laboratories has received the Establishment Inspection Report (EIR) for its AP...
06 Sep 202409:14
FAQs for 52 Week High of Dr Reddys Laboratories Ltd
What is the significance of Dr Reddys Laboratories Ltd reaching its 52-week high?
Why do investors monitor Dr Reddys Laboratories Ltd 52-week high?
Is Dr Reddys Laboratories Ltd a good buy when it hits its 52-week high?
What should I consider before investing in Dr Reddys Laboratories Ltd at its 52-week high?
Can Dr Reddys Laboratories Ltd stock price continue to rise after reaching its 52-week high?
Unlimited trading at just
Rs. 199*